The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth

Epidermal homeostasis depends on the coordinated control of keratinocyte cell cycle. Differentiation and the alteration of this balance can result in neoplastic development. Here we report on a novel DLX3-dependent network that constrains epidermal hyperplasia and squamous tumorigenesis. By integrating genetic and transcriptomic approaches, we demonstrate that DLX3 operates through a p53-regulated network. DLX3 and p53 physically interact on the p21 promoter to enhance p21 expression. Elevating DLX3 in keratinocytes produces a G1-S blockade associated with p53 signature transcriptional profiles. In contrast, DLX3 loss promotes a mitogenic phenotype associated with constitutive activation of ERK. DLX3 expression is lost in human skin cancers and is extinguished during progression of experimentally induced mouse squamous cell carcinoma (SCC). Reinstatement of DLX3 function is sufficient to attenuate the migration of SCC cells, leading to decreased wound closure. Our data establish the DLX3–p53 interplay as a major regulatory axis in epidermal differentiation and suggest that DLX3 is a modulator of skin carcinogenesis.

[1]  M. Morasso,et al.  Regulation of the Dlx3 Homeobox Gene upon Differentiation of Mouse Keratinocytes* , 1999, The Journal of Biological Chemistry.

[2]  M. Morasso,et al.  Regulation of epidermal differentiation by a Distal-less homeodomain gene , 1996, The Journal of cell biology.

[3]  M. Blumenberg,et al.  Transcriptional profiling of epidermal differentiation. , 2006, Physiological genomics.

[4]  D. Lowy,et al.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue , 1986, Nature.

[5]  Ryan W. Hick,et al.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. , 2012, The Journal of clinical investigation.

[6]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[7]  C. Banwell,et al.  Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor , 2006, Nucleic acids research.

[8]  M. Yi,et al.  IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis , 2012, The Journal of experimental medicine.

[9]  Rugang Zhang,et al.  RAS, cellular senescence and transformation , 2012, Small GTPases.

[10]  A. Sivachenko,et al.  A Landscape of Driver Mutations in Melanoma , 2012, Cell.

[11]  Gerry Melino,et al.  ΔNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2 , 2007, Proceedings of the National Academy of Sciences.

[12]  G. Melino,et al.  p63, a story of mice and men. , 2011, The Journal of investigative dermatology.

[13]  S. Sinha,et al.  ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation , 2012, Development.

[14]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[15]  A. Gandarillas.  The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint , 2012, Cell cycle.

[16]  A. Levine,et al.  The P53 pathway: what questions remain to be explored? , 2006, Cell Death and Differentiation.

[17]  Milind B. Suraokar,et al.  TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs , 2010, Nature.

[18]  L. Ellisen,et al.  p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. , 2006, Cancer cell.

[19]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[20]  M. Morasso,et al.  Role of homeobox genes in the patterning, specification, and differentiation of ectodermal appendages in mammals , 2008, Journal of cellular physiology.

[21]  F. McKeon,et al.  p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia , 2007, Cell.

[22]  J. C. Belmonte,et al.  Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells , 2010, Nature Protocols.

[23]  Boon Kiat Ng,et al.  Transcriptional control of late differentiation in human keratinocytes by TAp63 and Notch , 2015, Experimental dermatology.

[24]  Jiali Han,et al.  Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. , 2013, Journal of the American Academy of Dermatology.

[25]  E. Flores,et al.  p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis , 2013, Nature Reviews Cancer.

[26]  E. Glusac,et al.  p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma , 2006, Journal of cutaneous pathology.

[27]  G. Dotto,et al.  p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Morasso,et al.  Dlx genes, p63, and ectodermal dysplasias. , 2005, Birth defects research. Part C, Embryo today : reviews.

[29]  K. E. King,et al.  p63: Defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis , 2007, Molecular carcinogenesis.

[30]  A. Børresen-Dale,et al.  TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes , 2007, Oncogene.

[31]  J. Lian,et al.  Molecular Consequences of a Frameshifted DLX3 Mutant Leading to Tricho-Dento-Osseous Syndrome* , 2008, Journal of Biological Chemistry.

[32]  K. E. King,et al.  Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63 , 2013, Journal of skin cancer.

[33]  J. Pietenpol,et al.  p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. , 2007, Oncogene.

[34]  D. Roop,et al.  p63 and epithelial appendage development. , 2004, Differentiation; research in biological diversity.

[35]  M. Priolo,et al.  Ectodermal dysplasias: a new clinical-genetic classification , 2001, Journal of medical genetics.

[36]  D. Bae,et al.  Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion , 2007, Oncogene.

[37]  G. Merlo,et al.  Homeobox gene Dlx3 is regulated by p63 during ectoderm development: relevance in the pathogenesis of ectodermal dysplasias , 2007, Development.

[38]  Christopher P Crum,et al.  p63 in epithelial survival, germ cell surveillance, and neoplasia. , 2010, Annual review of pathology.

[39]  G. Melino,et al.  How the TP53 Family Proteins TP63 and TP73 Contribute to Tumorigenesis: Regulators and Effectors , 2014, Human mutation.

[40]  Chris T. A. Evelo,et al.  WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..

[41]  P. Burns,et al.  Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. , 1977, British Journal of Cancer.

[42]  S. Lowe,et al.  TAp63 induces senescence and suppresses tumorigenesis in vivo , 2009, Nature Cell Biology.

[43]  L. Guerrini,et al.  Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation , 2009, Cell cycle.

[44]  K. Tsai,et al.  Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8 , 2014, Proceedings of the National Academy of Sciences.

[45]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[46]  K. Tsai,et al.  TAp63 prevents premature aging by promoting adult stem cell maintenance. , 2009, Cell stem cell.

[47]  F. Di Cunto,et al.  The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. , 1996, Genes & development.

[48]  S. Jay,et al.  Dysregulated ΔNp63α Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes , 2011, PloS one.

[49]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[50]  Yonghong Xiao,et al.  FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.

[51]  Seung Hun Lee,et al.  Epidermal ablation of Dlx3 is linked to IL-17–associated skin inflammation , 2011, Proceedings of the National Academy of Sciences.

[52]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[53]  E. Flores.  The Roles of p63 in Cancer , 2007, Cell cycle.

[54]  S. Yuspa,et al.  Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. , 2009, Cancer research.

[55]  Maria I Morasso,et al.  Dlx3 is a crucial regulator of hair follicle differentiation and cycling , 2008, Development.

[56]  Anita Driessen-Mol,et al.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes. , 2014, Cold Spring Harbor perspectives in medicine.

[57]  Bi-He Cai,et al.  A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63. , 2012, Journal of biochemistry.

[58]  Jean Kanitakis,et al.  Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes , 2012, Cell Death and Disease.

[59]  E. Flores,et al.  p53/p63/p73 in the epidermis in health and disease. , 2014, Cold Spring Harbor perspectives in medicine.

[60]  S. Yuspa,et al.  Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice , 2008, Nature Protocols.

[61]  C. Abate-Shen.  Deregulated homeobox gene expression in cancer: cause or consequence? , 2002, Nature Reviews Cancer.